Sidley Advises Pivotal bioVenture Partners China and Frazier Healthcare Partners in Formation of SanReno Therapeutics with Chinook Therapeutics

Dec 13, 2021

Sidley Represents Venus Medtech in Acquisition of Cardiovalve

Dec 13, 2021

Sidley’s Global Life Sciences Practice Adds Nine Team Members, Including Five FDA Veterans and a Former Swissmedic Advisor

Dec 13, 2021

Bristol Myers Squibb Awards “Golden Tickets” to Promising Biotechs for Residencies at LabCentral, Biolabs@NYULangone and MBC BioLabs

Dec 02, 2021

Posted by Bristol Myers Squibb

FDA Articulates High Benefit-Risk Expectations For Drug Developers

Nov 23, 2021

Sidley Advises Tricida in Registered Direct Equity Offering

Nov 23, 2021

Sidley Advises IO Biotech in IPO

Nov 23, 2021

Sidley Advised KKR on Its Investment in Biosynth Carbosynth

Nov 23, 2021

SEC Dramatically Changes the Rules for Proxy Contests, Adopts Universal Proxy

Nov 23, 2021

Shortages of Medicinal Products Tackled by EU Regulators

Nov 23, 2021